KYNTRA BIO, INC. ·

KYNB 8-K 2026-10-01

KYNTRA BIO, INC. (KYNB) 8-K dated 2026-10-01 — accession 0001193125-26-409819. This URL is the filing, not the KYNB hub.

KYNTRA BIO, INC. (KYNB) common stock.

KYNTRA BIO, INC. filed a 8-K on 2026-10-01. Accession 0001193125-26-409819.

Cached items: 5.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported KYNB revenue for 2025-12-31 was $6.4M. Net income was $183.5M. Revenue was down 78.3% from 2024-12-31 to 2025-12-31.

Not investment advice. The KYNB SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR

Lician Pro $19.99/mo or $149/yr